Health Monitor Liechtenstein
SEE OTHER BRANDS

Your health and wellness news reporter from Liechtenstein

Welcome to Health Monitor Liechtenstein

Health Monitor Liechtenstein

Press Releases

Working Visit of His Serene Highness Hereditary Prince Alois Philipp Maria of the Principality of Liechtenstein to Singapore, 1 to 4 November 2024

Working Visit of His Serene Highness Hereditary Prince Alois Philipp Maria of the Principality of Liechtenstein to Singapore, 1 to 4 November 2024

His Serene Highness Hereditary Prince Alois Philipp Maria of the Principality of Liechtenstein will make a working visit to Singapore from 1 November to 4 November 2024. During the visit, HSH Hereditary Prince Alois will meet President Tharman...

Owner:  Singaporean Government
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Show All
Health Monitor Liechtenstein

Latest News

What a Wales v Belgium win, loss or draw means for World Cup qualification
De Bruyne's penalty double fires Belgium to vital win over Wales
Is Princess Elisabeth of Belgium dating Prince Georg of Liechtenstein? The potential royal love match explained
Palace Says Viral Photo of Belgium's Future Queen and Prince Georg of Liechtenstein Is Fake By Stephanie Petit
To what extent will Trump's tariffs impact Indian pharma? Govt assesses likely cost
Compliance Expert Calls for Transparency and Safeguards as New EU Border System Goes Live

Compliance Expert Calls for Transparency and Safeguards as New EU Border System Goes Live

As the EU’s new Entry/Exit System (EES) comes into effect this week, requiring most non-EU travellers to register biometric data such as fingerprints and facial scans at the border, digital compliance expert SmartSearch is calling for greater...

Owner:  Muzaffar Karabaev
Work stress and bad diets raising heart disease risk in UAE's under 50s
Dr. Reddy's receives positive CHMP opinion from European Medicines Agency for AVT03 - denosumab
Dr Reddy’s biosimilar gets nod from European Medical Agency’s panel

Dr Reddy’s biosimilar gets nod from European Medical Agency’s panel

Dr. Reddy’s commercialisation rights are exclusive for the U.S., and semi-exclusive for Europe and the UK | Photo Credit: Picasa The European Medical Agency’s (EMA) committee for Medicinal Products for Human Use (CHMP) has recommended AVT03, a...

Owner:  The Kasturi Family
Show All

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions